GlassScriptPhysician profile
Eugene Shostak
NPI 1851574453
$52,114.42
in general payments reported to CMS, 2019-2025
17 companies · $27K in 2025
The $27K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,090 · 2020: $1,932 · 2021: $1,851 · 2022: $8,054 · 2023: $3,259 · 2024: $2,867 · 2025: $27K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $2,663 · Consulting Fee: $1,900 · Travel and Lodging: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $17,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,500.00 |
| Food and Beverage | $2,663.16 |
| Consulting Fee | $1,900.00 |
| Travel and Lodging | $124.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $31,385.08 | 2020-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $11,678.19 | 2019-2024 | Tagrisso |
| Siemens Medical Solutions USA, INC. | $4,249.91 | 2025 | Cios Spin |
| Medtronic, INC. | $1,458.37 | 2021-2022 | |
| Covidien LP | $749.62 | 2019 | |
| Pulmonx Corporation | $646.47 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Ge Healthcare | $500.00 | 2025 | |
| Pinnacle Biologics, INC | $397.79 | 2019-2025 | Photofrin |
| Olympus America INC. | $355.00 | 2022-2025 | Spin Vision Video Processor, Visiglide |
| Ethicon INC. | $168.94 | 2019 | |
| Janssen Biotech, INC. | $141.91 | 2025 | Tremfya |
| Galvanize Therapeutics, INC | $125.00 | 2025 | Aliya System |
| Steris Corporation | $89.04 | 2025 | |
| Olympus Corporation of The Americas | $69.62 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $44.75 | 2024 | Dificid, Zerbaxa, Recarbrio |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $32.20 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.53 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Shostak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.